Search Results

There are 7692 results for: content related to: A systematic review of validated methods for identifying atrial fibrillation using administrative data

  1. Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 718–728, Kueiyu Joshua Lin, Luis A. García Rodríguez and Sonia Hernández-Díaz

    Article first published online : 27 MAY 2011, DOI: 10.1002/pds.2153

  2. Safety profile of oseltamivir during the 2009 influenza pandemic

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 5, May 2011, Pages: 532–543, Barbara Donner, Silvia Bader-Weder, Roman Schwarz, Michael M. Peng, James Robert Smith and Viswanathan Niranjan

    Article first published online : 29 MAR 2011, DOI: 10.1002/pds.2136

  3. Safety aspects of antiepileptic drugs—focus on pharmacovigilance

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 11–20, Cecilie Johannessen Landmark and Svein I. Johannessen

    Article first published online : 8 NOV 2011, DOI: 10.1002/pds.2269

  4. You have free access to this content
    When should case-only designs be used for safety monitoring of medical products?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 50–61, Malcolm Maclure, Bruce Fireman, Jennifer C. Nelson, Wei Hua, Azadeh Shoaibi, Antonio Paredes and David Madigan

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2330

  5. You have free access to this content
    A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 100–128, Susan E. Andrade, Leslie R. Harrold, Jennifer Tjia, Sarah L. Cutrona, Jane S. Saczynski, Katherine S. Dodd, Robert J. Goldberg and Jerry H. Gurwitz

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2312

  6. Data sources on drug safety evaluation: a review of recent published meta-analyses

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 21–33, Carlos Alves, Francisco Batel-Marques and Ana Filipa Macedo

    Article first published online : 25 OCT 2011, DOI: 10.1002/pds.2260

  7. You have free access to this content
    Design considerations in an active medical product safety monitoring system

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 32–40, Joshua J. Gagne, Bruce Fireman, Patrick B. Ryan, Malcolm Maclure, Tobias Gerhard, Sengwee Toh, Jeremy A. Rassen, Jennifer C. Nelson and Sebastian Schneeweiss

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2316

  8. Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 442–449, Tim A. Bruckner, Ashley Hodgson, Chris Brown Mahoney, Brent D. Fulton, Peter Levine and Richard M. Scheffler

    Article first published online : 24 OCT 2011, DOI: 10.1002/pds.2264

  9. Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005–2010

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1269–1277, Benedikt Fischer, Wayne Jones, Murray Krahn and Jürgen Rehm

    Article first published online : 13 JUL 2011, DOI: 10.1002/pds.2190

  10. You have free access to this content
    A systematic review of validated methods for identifying orthopedic implant removal and revision using administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S1, January 2012, Pages: 265–273, Jasvinder A Singh, Joseph A Kundukulam and Mohit Bhandari

    Article first published online : 19 JAN 2012, DOI: 10.1002/pds.2309

  11. Trends in emergency department visits attributable to acetaminophen overdoses in the United States: 1993–2007

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 810–818, Chenghui Li and Bradley C. Martin

    Article first published online : 18 JAN 2011, DOI: 10.1002/pds.2103

  12. Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 11, November 2011, Pages: 1168–1176, Susan E. Andrade, Tiffany A. Moore Simas, Denise Boudreau, Marsha A. Raebel, Sengwee Toh, Beth Syat, Inna Dashevsky and Richard Platt

    Article first published online : 22 AUG 2011, DOI: 10.1002/pds.2217

  13. Inhaled corticosteroid adherence in paediatric patients: the PACMAN cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1064–1072, Ellen S. Koster, Jan A. M. Raaijmakers, Susanne J. H. Vijverberg and Anke-Hilse Maitland-van der Zee

    Article first published online : 24 AUG 2011, DOI: 10.1002/pds.2228

  14. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 8, August 2011, Pages: 785–796, Kristian B. Filion, Lawrence Joseph, Jean-François Boivin, Samy Suissa and James M. Brophy

    Article first published online : 13 JUN 2011, DOI: 10.1002/pds.2165

  15. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 626–634, Dominik Rottenkolber, Sven Schmiedl, Marietta Rottenkolber, Katrin Farker, Karen Saljé, Silke Mueller, Marion Hippius, Petra A. Thuermann, Joerg Hasford and for the Net of Regional Pharmacovigilance Centers

    Article first published online : 8 MAR 2011, DOI: 10.1002/pds.2118

  16. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 10, October 2011, Pages: 1035–1042, Vanessa Stevens, Ghinwa Dumyati, Jack Brown and Edwin van Wijngaarden

    Article first published online : 10 AUG 2011, DOI: 10.1002/pds.2198

  17. Record linkage for pharmacoepidemiological studies in cancer patients

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 1, January 2012, Pages: 94–103, Myrthe P. P. van Herk-Sukel, Valery E. P. P. Lemmens, Lonneke V. van de Poll-Franse, Ron M. C. Herings and Jan Willem W. Coebergh

    Article first published online : 2 AUG 2011, DOI: 10.1002/pds.2205

  18. Stroke risk and NSAIDs: a systematic review of observational studies

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 12, December 2011, Pages: 1225–1236, Cristina Varas-Lorenzo, Nuria Riera-Guardia, Brian Calingaert, Jordi Castellsague, Antoine Pariente, Lorenza Scotti, Miriam Sturkenboom and Susana Perez-Gutthann

    Article first published online : 3 OCT 2011, DOI: 10.1002/pds.2227

  19. Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 7, July 2011, Pages: 700–708, Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun and Soko Setoguchi

    Article first published online : 14 MAY 2011, DOI: 10.1002/pds.2146

  20. Effects of epilepsy and selected antiepileptic drugs on risk of myocardial infarction, stroke, and death in patients with or without previous stroke: a nationwide cohort study

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 9, September 2011, Pages: 964–971, Jonas Bjerring Olesen, Steen Zabell Abildstrøm, Jesper Erdal, Gunnar H. Gislason, Peter Weeke, Charlotte Andersson, Christian Torp-Pedersen and Peter Riis Hansen

    Article first published online : 18 JUL 2011, DOI: 10.1002/pds.2186